HILL STEPHEN J. (Chief Technical Ops. Officer) sold 2.0% of their position (185.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $1.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/13/2025ACC: 0001415889-25-021693
Officer· Chief Technical Ops. Officer
Since Jun 2021
-185.00
Net shares
Net seller
$1.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
185.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−91.00
Price / share
$10.53
Trade value
$957.87
% of position
1.0%
8/11/2025
9.03K→8.94K
Common Stock
Direct
Shares
−94.00
Price / share
$10.34
Trade value
$971.77
% of position
1.1%
8/12/2025
8.94K→8.85K
Total
Net shares
−185.00
Net value
-$1.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2025 | S · Sale | −91.00 | $10.53 | $957.87 | 1.0% | 9.03K | 8.94K |
| Common Stock Direct | 8/12/2025 | S · Sale | −94.00 | $10.34 | $971.77 | 1.1% | 8.94K | 8.85K |
| Total | −185.00 | -$1.93K | ||||||
Derivative Transactions0
No derivative transactions reported